A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

Clinical trial NCT06952010 · RECRUITING

Trial details

NCT number: NCT06952010
Sponsor: Exelixis
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Advanced Solid Tumor Metastatic Solid Tumor Immune Sensitive Tumor

Start date: 2025-05-01
Primary completion: 2027-05-31
Enrollment: 303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.